Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marpadga A Reddy

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Cardiovascular Research|January 27, 2011
Epigenetic mechanisms in diabetic vascular complicationsMarpadga A Reddy, Rama Natarajan
Sub-Cellular Biochemistry|November 15, 2012
Role of epigenetic mechanisms in the vascular complications of diabetesMarpadga A Reddy, Rama Natarajan
Journal of the American Society of Nephrology : JASN|October 25, 2011
Epigenetics in diabetic kidney diseaseMarpadga A Reddy, Rama Natarajan
Kidney International|May 21, 2015
Recent developments in epigenetics of acute and chronic kidney diseasesMarpadga A Reddy, Rama Natarajan
Diabetes|May 22, 2016
Targeting miR-200c to Ameliorate Diabetes-Induced Endothelial DysfunctionMarpadga A Reddy, Rama Natarajan
American Journal of Physiology. Renal Physiology|January 25, 2021
Cooperative activation of divergent pathways by LPAR1 and LPAR2 receptors in fibrotic signalingMarpadga A Reddy, Rama Natarajan
Diabetologia|December 8, 2014
Epigenetic mechanisms in diabetic complications and metabolic memoryMarpadga A Reddy, Erli Zhang, Rama Natarajan
Current Opinion in Cardiology|March 25, 2020
Role of epigenetic mechanisms regulated by enhancers and long noncoding RNAs in cardiovascular diseaseSadhan Das, Marpadga A Reddy, Rama Natarajan
The Journal of Biological Chemistry|October 16, 2008
Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end productsNarkunaraja Shanmugam, Marpadga A Reddy, Rama Natarajan
Kidney Research and Clinical Practice|February 20, 2016
Epigenetic modifications and diabetic nephropathyMarpadga A Reddy, Jung Tak Park, Rama Natarajan
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Cardiovascular Research|January 27, 2011
Epigenetic mechanisms in diabetic vascular complicationsMarpadga A Reddy, Rama Natarajan
Sub-Cellular Biochemistry|November 15, 2012
Role of epigenetic mechanisms in the vascular complications of diabetesMarpadga A Reddy, Rama Natarajan
Journal of the American Society of Nephrology : JASN|October 25, 2011
Epigenetics in diabetic kidney diseaseMarpadga A Reddy, Rama Natarajan
Kidney International|May 21, 2015
Recent developments in epigenetics of acute and chronic kidney diseasesMarpadga A Reddy, Rama Natarajan
Diabetes|May 22, 2016
Targeting miR-200c to Ameliorate Diabetes-Induced Endothelial DysfunctionMarpadga A Reddy, Rama Natarajan
American Journal of Physiology. Renal Physiology|January 25, 2021
Cooperative activation of divergent pathways by LPAR1 and LPAR2 receptors in fibrotic signalingMarpadga A Reddy, Rama Natarajan
Diabetologia|December 8, 2014
Epigenetic mechanisms in diabetic complications and metabolic memoryMarpadga A Reddy, Erli Zhang, Rama Natarajan
Current Opinion in Cardiology|March 25, 2020
Role of epigenetic mechanisms regulated by enhancers and long noncoding RNAs in cardiovascular diseaseSadhan Das, Marpadga A Reddy, Rama Natarajan
The Journal of Biological Chemistry|October 16, 2008
Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end productsNarkunaraja Shanmugam, Marpadga A Reddy, Rama Natarajan
Kidney Research and Clinical Practice|February 20, 2016
Epigenetic modifications and diabetic nephropathyMarpadga A Reddy, Jung Tak Park, Rama Natarajan
Pageof 6